Spinogenix, Inc., 2026-03-09
An SEC Form D private-offering notice from Los Angeles, CA, a $35,000,000 filer-stated offering target in Biotech. Filed 2026-03-09. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biopharmaceutical company developing oral small molecule drugs to regenerate brain synapses for ALS, schizophrenia, Alzheimer's, and Fragile X syndrome.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- ASCENT HOLDING CO., 2026-03-10, $45.7M, San Diego, CA
- Solstice Oncology, Inc., 2026-03-09, $298.4M, Boston, MA
- AirNexis Therapeutics, Inc., 2026-03-09, $200M, Palo Alto, CA
- Tolero H2 Inc., 2026-03-09, $5M, Sacramento, CA
- iotaMotion, Inc., 2026-03-09, $10M, St. Paul, MN
- 10K Health, LLC, 2026-03-06, $3.6M, Beverly Hills, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.